News Articles and Montana BioScience Alliance Newsletters
Montana State University has joined with a dozen other universities in the region to form a partnership aimed at creating economic development opportunities around emerging high-tech industries.
INDUSTRY Bozeman, a multi-tenant modern office space, has broken ground on an 87,000-square-foot building to be located on the Montana State University Innovation Campus.
Montana’s Tonix Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Boston Children’s Hospital to study TNX-15001 (Fc-modified anti-CD40L mAb) for the prevention of graft-versus-host disease (GvHD) after hematopoietic stem cell transplantation (HCT) in animals.
The University of Montana recently secured $5.1 million in federal grants from the Health Resource and Service Administration, leading to the formation of a new UM Office of Health Research & Partnership. The office will use the HRSA funding for programs to bolster the health care workforce and increase access to quality health care in rural and underserved parts of Montana.
MSU Associate Professor of Molecular Biology Lynn George, Ph.D., was recently awarded a National Institutes of Health Academic Research Enhancement Award (AREA) from the National Institute of Neurological Disorders and Stroke. This three-year, $385,000 grant will support George’s efforts to continue and expand her research on Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. George’s grant proposal scored in the top one percentile, which is laudable, given the highly competitive nature of NIH funding.
The NIA is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2024, unless otherwise noted.
The Senate has voted to confirm President Joe Biden’s pick to run the National Institutes of Health (NIH), Dr. Monica Bertagnolli, filling the director spot at the country’s top medical research agency after a vacancy of almost two years.
Updates from product development and small business programs
Are you working to develop an innovative cancer technology? Take a step forward in your commercialization journey through the newly released FY2024 SBIR Contract Solicitation! This funding opportunity aims to provide early-stage funding to small businesses that are developing cancer technologies in areas defined by the National Cancer Institute.
The U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit.